$EVGN News

Last published 2w ago

2w agoEVGNEvogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery ProgramPR NewswireAdvancing a First-in-Class Small-Molecule Therapeutic, Guided by World-Leading Experts, to Address a Multi-Billion-Dollar Unmet Need in Steroid-Refractory PatientsREHOVOT, Israel, Oct. 28, 2026 /PRNewswire/ -- Evogene
2w agoEVGNEvogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in SpainPR NewswireCompany to Attend BIO-Europe in Cologne, Germany, and Present a Scientific Poster at Drug Discovery Chemistry Europe in Barcelona, SpainREHOVOT, Israel, Oct. 26, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE:
3w agoEVGNEvogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeILPR NewswireThe roadshow will connect leading Israeli AI-driven drug discovery and biotechnology companies with U.S. investors, pharmaceutical companies, and potential strategic partnersREHOVOT, Israel, Oct. 20, 2026 /PRNewswire/
1mo agoEVGNEvogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of DirectorsPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneer in computational chemistry specializing in the generative design of small molecules for the...
1mo agoEVGNEvogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price CompliancePR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a pioneer in computational chemistry specializing in the generative design of...
2mo agoEVGNEvogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path ForwardPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneer in computational chemistry specializing in the generative design of small molecules for the...
2mo agoEVGNLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director NomineesPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules...
2mo agoEVGNEvogene Reports Second Quarter and First Half 2026 Financial ResultsPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules...
2mo agoEVGNEvogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders SituationPR NewswireZoom conference call scheduled for August 18, 2026, at 9:00 AM ETREHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in
3mo agoEVGNEvogene Schedules Second Quarter 2026 Financial Results ReleasePR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules...
3mo agoEVGNEvogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular DiseasesPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for...
3mo agoEVGNAgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ CapabilitiesPR NewswireAgPlenus Ltd., a company developing novel, sustainable crop protection products and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today...
4mo agoEVGNEvogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug DiscoveryPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the generative design of small molecules for the...
4mo agoEVGNEvogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and OptimizationPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a computational biology and chemistry company leveraging artificial intelligence (AI) to discover and...
4mo agoEVGNEarnings Call - EVOGENE LTDEarnings Call TranscriptsHello and good day, everyone. Thank you for your interest in Evogen. We are pleased to share with you the story of our company as we continue our path to success. Evogen is a publicly traded company listed in the Nasdaq
5mo agoEVGNEvogene to Present Its Pharma Division Achievements at the BIO International ConventionPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in AI-based generative design of small...
5mo agoEVGNEvogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary BiomicaPR NewswireEvogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in generative design of small...
5mo agoEVGNEvogene Reports First Quarter 2026 Financial ResultsPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules ...
6mo agoEVGNEvogene to Present at the 24th Schrödinger European User Group MeetingPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules ...
6mo agoEVGNEvogene Schedules First Quarter 2026 Financial Results ReleasePR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules...
7mo agoEVGNEvogene Reports Receipt of Nasdaq Minimum Bid Price NotificationPR NewswireEvogene Ltd. (NASDAQ: EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative...
8mo agoEVGNEvogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026PR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules ...
8mo agoEVGNEvogene Reports Fourth Quarter and Full Year 2025 Financial ResultsPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules ...
8mo agoEVGNEvogene Releases CEO Letter to ShareholdersPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative AI design of small molecules...
8mo agoEVGNEvogene Schedules Fourth Quarter and Full Year 2025 Financial Results ReleasePR NewswireEvogene Ltd . (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules...
8mo agoEVGNEvogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer TherapeuticsPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for...
9mo agoEVGNEvogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory DiseasesPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for...
9mo agoEVGNEvogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross ProceedsPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene" or the "Company"), a pioneering computational chemistry company, specializing in the generative...
9mo agoEVGNEvogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™PR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a computational chemistry company focused on AI-driven small-molecule design for the pharmaceutical and...
9mo agoEVGNEvogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory BoardPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the AI-driven discovery and design of novel small...
9mo agoEVGNEvogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung CancerPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene"), a pioneering computational chemistry company specializing in generative design of small...
10mo agoEVGNEvogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating DisordersPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company, specializing in the generative design of small molecules for...
10mo agoEVGNEvogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business DevelopmentPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small molecules...
11mo agoEVGNEvogene Reports Third Quarter 2025 Financial ResultsPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small molecules...
1y agoEVGNCasterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor FarmingPR NewswireCasterra Ag Ltd. ("Casterra"), an Israeli developer of high-yield castor seed varieties and integrated castor farming solutions — and a subsidiary of ...
1y agoEVGNEvogene Schedules Third Quarter 2025 Financial Results ReleasePR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules...
1y agoEVGNEvogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New YorkPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President ...
1y agoEVGNEvogene Ltd. (EVGN) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoEVGNEvogene Reports Second Quarter 2025 Financial ResultsPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company aiming to revolutionize the development of...
1y agoEVGNEvogene Schedules Second Quarter 2025 Financial Results ReleasePR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
1y agoEVGN ICLEvogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICLPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive...
1y agoEVGNEvogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google CloudPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and...
1y agoEVGNEvogene Reports First Quarter 2025 Financial ResultsPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based...
1y agoEVGNEvogene Schedules First Quarter 2025 Financial Results ReleasePR NewswireMay 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product...
1y agoEVGNICL to Acquire the Activity of Evogene's Subsidiary, Lavie BioPR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and...
1y agoEVGNEvogene Reports Fourth Quarter and Full Year 2024 Financial ResultsPR NewswireEvogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based...
1y agoEVGNEvogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025PR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and...
1y agoEVGNEvogene Schedules Fourth Quarter 2024 Financial Results ReleasePR NewswireEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
1y agoEVGNAgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat DiseasePR NewswireAgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) ...
1y agoEVGNEvogene Ltd. (EVGN) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts